177 related articles for article (PubMed ID: 32001608)
1. Biological mechanisms and individual variation in fibrinolysis after major trauma.
Coats TJ; Morsy M
Emerg Med J; 2020 Mar; 37(3):135-140. PubMed ID: 32001608
[TBL] [Abstract][Full Text] [Related]
2. Does Tranexamic Acid Improve Clot Strength in Severely Injured Patients Who Have Elevated Fibrin Degradation Products and Low Fibrinolytic Activity, Measured by Thrombelastography?
Moore HB; Moore EE; Chapman MP; Hansen KC; Cohen MJ; Pieracci FM; Chandler J; Sauaia A
J Am Coll Surg; 2019 Jul; 229(1):92-101. PubMed ID: 30936005
[TBL] [Abstract][Full Text] [Related]
3. Fibrinolysis in trauma patients: wide variability demonstrated by the Lysis Timer.
Roullet S; Weinmann L; Labrouche S; Gisbert-Mora C; Biais M; Revel P; Freyburger G
Scand J Clin Lab Invest; 2019; 79(1-2):136-142. PubMed ID: 30861350
[TBL] [Abstract][Full Text] [Related]
4. Rationale for the selective administration of tranexamic acid to inhibit fibrinolysis in the severely injured patient.
Moore EE; Moore HB; Gonzalez E; Sauaia A; Banerjee A; Silliman CC
Transfusion; 2016 Apr; 56 Suppl 2(Suppl 2):S110-4. PubMed ID: 27100746
[TBL] [Abstract][Full Text] [Related]
5. Tranexamic acid mediates proinflammatory and anti-inflammatory signaling via complement C5a regulation in a plasminogen activator-dependent manner.
Barrett CD; Moore HB; Kong YW; Chapman MP; Sriram G; Lim D; Moore EE; Yaffe MB
J Trauma Acute Care Surg; 2019 Jan; 86(1):101-107. PubMed ID: 30575685
[TBL] [Abstract][Full Text] [Related]
6. Point-of-care testing for tranexamic acid efficacy: a proof-of-concept study in cardiac surgical patients.
Yoshii R; Takahashi Y; Tanaka KA; Kawajiri H; Sawa T; Amaya F; Ogawa S
Br J Anaesth; 2024 Jun; 132(6):1211-1218. PubMed ID: 38677950
[TBL] [Abstract][Full Text] [Related]
7. Tranexamic acid administration in the field does not affect admission thromboelastography after traumatic brain injury.
Dixon AL; McCully BH; Rick EA; Dewey E; Farrell DH; Morrison LJ; McMullan J; Robinson BRH; Callum J; Tibbs B; Dries DJ; Jui J; Gandhi RR; Garrett JS; Weisfeldt ML; Wade CE; Aufderheide TP; Frascone RJ; Tallon JM; Kannas D; Williams C; Rowell SE; Schreiber MA
J Trauma Acute Care Surg; 2020 Nov; 89(5):900-907. PubMed ID: 33105308
[TBL] [Abstract][Full Text] [Related]
8. Early tranexamic acid administration ameliorates the endotheliopathy of trauma and shock in an in vitro model.
Diebel LN; Martin JV; Liberati DM
J Trauma Acute Care Surg; 2017 Jun; 82(6):1080-1086. PubMed ID: 28328682
[TBL] [Abstract][Full Text] [Related]
9. Systematic elucidation of effects of tranexamic acid on fibrinolysis and bleeding during and after cardiopulmonary bypass surgery.
Kojima T; Gando S; Morimoto Y; Mashio H; Goda Y; Kawahigashi H; Kemmotsu O
Thromb Res; 2001 Dec; 104(5):301-7. PubMed ID: 11738071
[TBL] [Abstract][Full Text] [Related]
10. Increased urokinase and consumption of α
Longstaff C; Locke M
J Thromb Haemost; 2019 Jan; 17(1):195-205. PubMed ID: 30451372
[TBL] [Abstract][Full Text] [Related]
11. Effective tranexamic acid concentration for 95% inhibition of tissue-type plasminogen activator induced hyperfibrinolysis in children with congenital heart disease: A prospective, controlled, in-vitro study.
Rozen L; Faraoni D; Sanchez Torres C; Willems A; Noubouossie DC; Barglazan D; Van der Linden P; Demulder A
Eur J Anaesthesiol; 2015 Dec; 32(12):844-50. PubMed ID: 26258658
[TBL] [Abstract][Full Text] [Related]
12. Effects of tranexamic acid on coagulofibrinolytic markers during the early stage of severe trauma: A propensity score-matched analysis.
Gando S; Shiraishi A; Wada T; Yamakawa K; Fujishima S; Saitoh D; Kushimoto S; Ogura H; Abe T; Mayumi T; Sasaki J; Kotani J; Takeyama N; Tsuruta R; Takuma K; Shiraishi SI; Shiino Y; Nakada TA; Okamoto K; Sakamoto Y; Hagiwara A; Fujimi S; Umemura Y; Otomo Y;
Medicine (Baltimore); 2022 Aug; 101(32):e29711. PubMed ID: 35960088
[TBL] [Abstract][Full Text] [Related]
13. Tranexamic acid rapidly inhibits fibrinolysis, yet transiently enhances plasmin generation in vivo.
Draxler DF; Zahra S; Goncalves I; Tran H; Hanafi G; Ho H; Keragala CB; Ilich A; Key NS; Myles PS; Medcalf RL
Blood Coagul Fibrinolysis; 2021 Apr; 32(3):172-179. PubMed ID: 33443933
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the in-vivo effect of two tranexamic acid doses on fibrinolysis parameters in adults undergoing valvular cardiac surgery with cardiopulmonary bypass - a pilot investigation.
Zhou ZF; Zhai W; Yu LN; Sun K; Sun LH; Xing XF; Yan M
BMC Anesthesiol; 2021 Feb; 21(1):33. PubMed ID: 33530942
[TBL] [Abstract][Full Text] [Related]
15. Synergism of red blood cells and tranexamic acid in the inhibition of fibrinolysis.
Raska A; Kálmán K; Egri B; Csikós P; Beinrohr L; Szabó L; Tenekedjiev K; Nikolova N; Longstaff C; Roberts I; Kolev K; Wohner N
J Thromb Haemost; 2024 Mar; 22(3):794-804. PubMed ID: 38016517
[TBL] [Abstract][Full Text] [Related]
16. An in vitro study of the effects of t-PA and tranexamic acid on whole blood coagulation and fibrinolysis.
Godier A; Parmar K; Manandhar K; Hunt BJ
J Clin Pathol; 2017 Feb; 70(2):154-161. PubMed ID: 27445340
[TBL] [Abstract][Full Text] [Related]
17. Fibrinolysis as a Causative Mechanism for Bleeding Complications on Extracorporeal Membrane Oxygenation: A Pilot Observational Prospective Study.
Helms J; Curtiaud A; Severac F; Tschirhart M; Merdji H; Bourdin M; Contant G; Depasse F; Abou Rjeily R; Sattler L; Meziani F; Angles-Cano E
Anesthesiology; 2024 Jul; 141(1):75-86. PubMed ID: 38502917
[TBL] [Abstract][Full Text] [Related]
18. Plasminogen activator inhibitor-1 suppresses endogenous fibrinolysis in a canine model of pulmonary embolism.
Reilly CF; Fujita T; Hutzelmann JE; Mayer EJ; Shebuski RJ
Circulation; 1991 Jul; 84(1):287-92. PubMed ID: 1905594
[TBL] [Abstract][Full Text] [Related]
19. Tranexamic acid is associated with reduced complement activation in trauma patients with hemorrhagic shock and hyperfibrinolysis on thromboelastography.
Barrett CD; Vigneshwar N; Moore HB; Ghasabyan A; Chandler J; Moore EE; Yaffe MB
Blood Coagul Fibrinolysis; 2020 Dec; 31(8):578-582. PubMed ID: 32732500
[TBL] [Abstract][Full Text] [Related]
20. Relationships between lipoprotein(a), lipids, apolipoproteins, basal and stimulated fibrinolytic regulators, and D-dimer.
Glueck CJ; Glueck HI; Tracy T; Speirs J; McCray C; Stroop D
Metabolism; 1993 Feb; 42(2):236-46. PubMed ID: 8474322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
